Author
Listed:
- Katharina L. Willmann
(CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna 1090, Austria)
- Stefanie Klaver
(CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna 1090, Austria
Institute of Biomedical Sciences, University of São Paulo)
- Figen Doğu
(Ankara University Medical School)
- Elisangela Santos-Valente
(CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna 1090, Austria)
- Wojciech Garncarz
(CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna 1090, Austria)
- Ivan Bilic
(CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna 1090, Austria)
- Emily Mace
(Center for Human Immunobiology, Baylor College of Medicine and Texas Children’s Hospital)
- Elisabeth Salzer
(CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna 1090, Austria)
- Cecilia Domínguez Conde
(CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna 1090, Austria)
- Heiko Sic
(Centre of Chronic Immunodeficiency, University Medical Centre Freiburg)
- Peter Májek
(CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna 1090, Austria)
- Pinaki P. Banerjee
(Center for Human Immunobiology, Baylor College of Medicine and Texas Children’s Hospital)
- Gregory I. Vladimer
(CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna 1090, Austria)
- Şule Haskoloğlu
(Ankara University Medical School)
- Musa Gökalp Bolkent
(Ankara University Medical School)
- Alphan Küpesiz
(Akdeniz University Medical School)
- Antonio Condino-Neto
(Institute of Biomedical Sciences, University of São Paulo)
- Jacques Colinge
(CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna 1090, Austria)
- Giulio Superti-Furga
(CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna 1090, Austria)
- Winfried F. Pickl
(Christian Doppler Laboratory for Immunomodulation and Institute of Immunology, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna)
- Menno C. van Zelm
(Erasmus MC, University Medical Center)
- Hermann Eibel
(Centre of Chronic Immunodeficiency, University Medical Centre Freiburg)
- Jordan S. Orange
(Center for Human Immunobiology, Baylor College of Medicine and Texas Children’s Hospital)
- Aydan Ikincioğulları
(Ankara University Medical School)
- Kaan Boztuğ
(CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna 1090, Austria
Medical University of Vienna)
Abstract
Primary immunodeficiency disorders enable identification of genes with crucial roles in the human immune system. Here we study patients suffering from recurrent bacterial, viral and Cryptosporidium infections, and identify a biallelic mutation in the MAP3K14 gene encoding NIK (NF-κB-inducing kinase). Loss of kinase activity of mutant NIK, predicted by in silico analysis and confirmed by functional assays, leads to defective activation of both canonical and non-canonical NF-κB signalling. Patients with mutated NIK exhibit B-cell lymphopenia, decreased frequencies of class-switched memory B cells and hypogammaglobulinemia due to impaired B-cell survival, and impaired ICOSL expression. Although overall T-cell numbers are normal, both follicular helper and memory T cells are perturbed. Natural killer (NK) cells are decreased and exhibit defective activation, leading to impaired formation of NK-cell immunological synapses. Collectively, our data illustrate the non-redundant role for NIK in human immune responses, demonstrating that loss-of-function mutations in NIK can cause multiple aberrations of lymphoid immunity.
Suggested Citation
Katharina L. Willmann & Stefanie Klaver & Figen Doğu & Elisangela Santos-Valente & Wojciech Garncarz & Ivan Bilic & Emily Mace & Elisabeth Salzer & Cecilia Domínguez Conde & Heiko Sic & Peter Májek & , 2014.
"Biallelic loss-of-function mutation in NIK causes a primary immunodeficiency with multifaceted aberrant lymphoid immunity,"
Nature Communications, Nature, vol. 5(1), pages 1-13, December.
Handle:
RePEc:nat:natcom:v:5:y:2014:i:1:d:10.1038_ncomms6360
DOI: 10.1038/ncomms6360
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:5:y:2014:i:1:d:10.1038_ncomms6360. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.